Podium Power

Call us Now

+41 44 741 8181

Call Back

Request Here

Make Appointment

Come to us @ ELZA

Email Us

info@elza-institute.com

Recommend Us

Thank you!

Telemedicine

Online consultation

  • Farhad Hafezi, Podium Power
ELZA surgeon invited speaker at Harvard University
ELZA founder Prof. Farhad Hafezi was one of two international guest speakers at the 31st Biennial Harvard Cornea Conference at the Schepens Eye Research Center at Harvard University in Boston, Massachusetts.
  • by Mark Hillen
  • September 23, 2019
Read More
  • Awards, Emilio Torres, Farhad Hafezi, Podium Power
Best Poster Prize at ESCRS is awarded to Emilio Torres-Netto
Dr. Emilio Torres-Netto’s moderated poster presentation “Stromal bed smoothness after excimer laser surface ablation as a key element for the expression of inflammatory genes”, which won the Best Poster Presentation Prize in the Refractive Surgery Section. Over 1000 posters were submitted to ESCRS; Torres-Netto et al.’s was considered to be the best.
  • by Mark Hillen
  • September 20, 2019
Read More
  • Awards, Emilio Torres, Farhad Hafezi, Lamis Baydoun, Nikki Hafezi, Podium Power
ELZA at ESCRS 2019: a record 21 presentations
The annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) was held in Paris between 14–18 September 2019, and ELZA’s surgeons and researchers presented a record 21 presentations during the congress – so what did ELZA at ESCRS manage to achieve? Our team presented at 8 free paper presentations and a further 8 instructional courses, as well as three moderated poster sessions, two e-posters (as well as instructing in 1 wet lab too).
  • by Mark Hillen
  • September 13, 2019
Read More
  • Farhad Hafezi, Nikki Hafezi, Podium Power
MEACO: ELZA goes to Jordan
I was honoured to be invited to give a series of talks during this year’s MEACO congress, held in the Hilton Dead Sea & Spa Hotel in Amman, Jordan, where I reviewed the latest thinking in cross-linking and presented the latest clinical and laboratory research work from our research group and our collaborators.
  • by Mark Hillen
  • September 5, 2019
Read More
  • Farhad Hafezi, Podium Power
Podium Power: Farhad Hafezi in Zagreb
ELZA’s medical director, Prof. Dr. Farhad Hafezi was invited to be the guest lecturer at the Croatian Ophthalmology and Optometric Society’s Contact Lens course, where he presented the latest corneal cross-linking (CXL) research and reviewed current best clinical practice for the treatment of keratoconus and iatrogenic ectasia.
  • by Mark Hillen
  • August 20, 2019
Read More
  • Lamis Baydoun, Podium Power
Being the Boss of the Graft
What I’ve learned in the last few years is not to be afraid of the grafts anymore! This is something that just at the beginning is quite frightening. You’re afraid of touching it, you’re afraid of the graft itself, because it behaves how it wants to behave, but with experience, you realise that no, I’ll tell you what to do, and it will do what you want.
  • by Prof. Farhad Hafezi
  • August 14, 2019
Read More
  • Awards, Dion Paridaens, Emilio Torres, Farhad Hafezi, Podium Power
ELZA’s Surgeons on the Podium and in the News
For the second year in a row, Dion Paridaens gave a series of lectures at the 2019 ESASO Course on Orbital, Lacrimal & Oculoplastic Surgery Course in Lugano, Switzerland (21–25 January, 2019).
  • by Mark Hillen
  • February 26, 2019
Read More
  • Farhad Hafezi, Podium Power
Cross-Linking in the USA – Part 3: Off-Label applications
Epi-on CXL aims to sidestep epi-off CXL’s issues by leaving the epithelium intact, however, this comes at a price of reduced efficacy – no clinical trial published to date has convincingly shown epi-on CXL to be as effective as epi-off CXL at the most important outcome: stopping keratoconus from progressing.
  • by Mark Hillen
  • February 6, 2019
Read More
  • Awards, Farhad Hafezi, Podium Power
Farhad Hafezi on being appointed FARVO
Being appointed FARVO – Fellow of the Association for Research in Vision and Ophthalmology – is a big deal for me. Let me tell you why…
  • by Mark Hillen
  • January 8, 2019
Read More
PREV1011121314Next
.
.